SRNE — Sorrento Therape · $385.9K cap

Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.

Use this SRNE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SRNE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SRNE SEC filings page. Lician reads the product cache first so this HTML stays unique to Sorrento Therape even when a live quote feed is slow.

Sorrento Therape latest statements (FY2022)

Latest cached year on this hub. Full SRNE income, balance, and cash tables.

  • Revenue$0
  • Net Income-$577.8M
  • Total Assets$472.8M
  • Total Debt$0
  • Free Cash Flow$0